Cited by 12

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Glutaredoxin 1 Downregulation in the Substantia Nigra Leads to Dopaminergic Degeneration in Mice

Verma, Aditi, Ray, Ajit, Bapat, Deepti, Diwakar, Latha, Kommaddi, Reddy Peera, Schneider, Bernard L., Hirsch, Etienne C., Ravindranath, Vijayalakshmi·2020·Movement Disorders

Abstract

Background: Parkinson's disease (PD) is characterized by a severe loss of the dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). Perturbation of protein thiol redox homeostasis has been shown to play a role in the dysregulation of cell death and cell survival signaling pathways in these neurons. Glutaredoxin 1 (Grx1) is a thiol/disulfide oxidoreductase that catalyzes the deglutathionylation of proteins and is important for regulation of cellular protein thiol redox homeostasis. Objectives: We evaluated if the downregulation of Grx1 could lead to dopaminergic degeneration and PD‐relevant motor deficits in mice. Methods: Grx1 was downregulated unilaterally through viral vector‐mediated transduction of short hairpin RNA against Grx1 into the SNpc. Behavioral assessment was performed through rotarod and elevated body swing test. Stereological analysis of tyrosine hydroxylase–positive and Nissl‐positive neurons was carried out to evaluate neurodegeneration. Results: Downregulation of Grx1 resulted in contralateral bias of elevated body swing and reduced latency to fall off, accelerating rotarod. This was accompanied by a loss of tyrosine hydroxylase–positive neurons in the SNpc and their DA projections in the striatum. Furthermore, there was a loss Nissl‐positive neurons in the SNpc, indicating cell death. This was selective to the SNpc neurons because DA neurons in the ventral tegmental area were unaffected akin to that seen in human PD. Furthermore, Grx1 mRNA expression was substantially decreased in the SNpc from PD patients. Conclusions: Our study indicates that Grx1 is critical for the survival of SNpc DA neurons and that it is downregulated in human PD. © 2020 International Parkinson and Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.28190

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 49

  1. 10.1111/j.1471-4159.1990.tb02325.x · DOI · Paper page
  2. 10.1038/nature05292 · DOI · Paper page
  3. 10.1016/j.expneurol.2009.03.006 · DOI
  4. 10.1111/jnc.13731 · DOI
  5. 10.1007/BF01244786 · DOI
  6. 10.1007/s00702-012-0905-9 · DOI
  7. 10.1002/mds.21013 · DOI
  8. Zheng Q, 2016, Dysregulation of ubiquitin‐proteasome system in neurodegenerative diseases, Front Aging Neurosci, 8
  9. 10.1002/ana.410320714 · DOI
  10. 10.1159/000118538 · DOI
  11. 10.1002/ana.10483 · DOI · Paper page
  12. 10.1089/ars.2011.4501 · DOI
  13. Johnson WM, 2015, The roles of redox enzymes in Parkinson's disease: focus on glutaredoxin, Ther Targets Neurol Dis, 2, e790
  14. 10.1016/j.freeradbiomed.2015.06.041 · DOI
  15. 10.1096/fj.11-194100 · DOI
  16. 10.1089/ars.2012.4644 · DOI
  17. 10.1021/bi00064a021 · DOI
  18. 10.1093/hmg/ddu542 · DOI
  19. 10.1089/ars.2009.2832 · DOI
  20. 10.1007/978-1-60327-295-7_7 · DOI
  21. 10.1038/mt.2008.73 · DOI
  22. 10.1016/j.jesp.2013.03.013 · DOI · Paper page
  23. 10.1523/JNEUROSCI.15-07-05372.1995 · DOI
  24. 10.1159/000017464 · DOI
  25. 10.1016/S0301-0082(99)00060-X · DOI · Paper page
  26. 10.1002/glia.20191 · DOI
  27. 10.1023/A:1021608724117 · DOI
  28. 10.1046/j.1471-4159.2002.00990.x · DOI
  29. 10.1046/j.1471-4159.1999.0721170.x · DOI
  30. 10.1016/j.bbagen.2012.09.018 · DOI
  31. 10.1016/S0306-4522(97)00347-3 · DOI
  32. 10.1523/JNEUROSCI.19-02-00562.1999 · DOI · Paper page
  33. 10.1038/s41418-018-0229-x · DOI
  34. 10.1155/2018/4235695 · DOI
  35. 10.1016/j.redox.2018.11.007 · DOI
  36. 10.1089/ars.2015.6598 · DOI
  37. 10.1371/journal.pone.0002459 · DOI
  38. 10.1096/fj.02-0771fje · DOI
  39. 10.1016/j.neuint.2007.03.008 · DOI
  40. 10.1101/cshperspect.a008888 · DOI
  41. 10.1093/brain/aww080 · DOI
  42. 10.1093/hmg/ddu542 · DOI
  43. 10.1096/fj.06-7580com · DOI
  44. 10.1016/j.freeradbiomed.2014.06.004 · DOI
  45. 10.3389/fnana.2014.00152 · DOI
  46. 10.1002/glia.23627 · DOI
  47. 10.1523/ENEURO.0167-17.2017 · DOI
  48. 10.1016/0306-4522(93)90175-F · DOI
  49. 10.1016/0304-3940(82)90390-1 · DOI

Metadata

Authors
Verma, A., Ray, A., Bapat, D., Diwakar, L., Kommaddi, R. P., Schneider, B. L., Hirsch, E. C., & Ravindranath, V.
Affiliations
  • Centre for Neuroscience Indian Institute of Science Bangalore India
  • Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne, CH‐1015 Lausanne Switzerland
  • Institut du Cerveau–ICM Inserm U 1127, CNRS UMR 7225, Sorbonne Université Paris France
Venue
Movement Disorders
Publisher
Wiley
Published
2020-07-03
Volume
35
Issue
10
Pages
1843-1853
ISSN
  • 0885-3185
  • 1531-8257
Cited by
12
References
3
Language
en
Funders
Tata Trusts (JTTO‐001)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review